exam 5 drugs Flashcards
open angle glaucoma tx
-PG analogs (-oprost) +
-B-blockers (-olol) -
-a2 (-inidine) +-
-carbonic anhydrqase inhibitors (-zolamide) -
-rho kinase inhibitors (netarsudil) +
-cholinergics (carbachol and pilocarpine) +
Apoliproteins
-ApoA: HDL, reverse cholesterol transport
-ApoB: 100 VLDL-LDL, 48 chylomicron
-ApoE: reverse choleserol transport w HDL
-ApoCII: TG hydrolysis
lipid transport
-EXO: chylomicrons + LPL from intestine
-ENDO: VLDL from liver to IDL (ApoE) then LDL (ApoB)
Hepatic lipase
-IDL to LDL
Hyperlipoproteinemia
-artheroclerosisi
-CAD
-stroke
HyperTG
-panreatitis
-xanthomas
-inc CHD risk
Artherosclerosis
-macrophages
-smooth muscle cells from injury
=foam cells
-oxidized LDL attract more macrophages
-ACAT1 esters cholesterol in macrophage
-CEH: frees cholesterol to ApoA1 or HDL
HoFH tx
-LDLR reduced
-lomitapide (juxtapid) (apoB)
-mipomersen (apoB)
-Evinacumab-dgnb (ANGPTL3)
juxtapid (lomitapide)
-inhibits ApoB lipoproteins in liver and intestine
-chylomicrons and VLDL-LDL
-restricted rx (liver)
Mipomersen
-anti-sense
-ApoB100 in liver inhibited
-SQ qweek
-restricted rx (hepatic steatosis)
Evinacumab-dgnd
-IV qmonth
-inc LPL and E(lipase_ by inhibiting ANDPTL
-gets rid of IDL before it turns into LDL
Hyper TG tx
-fibrates
-niacin
-omega-3
Fibric acid derivatives
-PPARa (transcription factor_
-aromatic ring-o-spacer grp-carbox
Niacin
-inc LPL to get rid of VLDL
-dec hepatic VLDL production (dec TG transport_
-dec FFA release (DGAT2) and transport to liver (GPR109A)
-dec CE content in macrophages by inc ABCA1 expression = HDL uptake
nonHDL-C=
TC-HDL
LDL=
TC-HDL -TG/5
-not valid when TGs >400
TC/HDL goal
<5:1
lifestyle changes dyslipidemia
-olestra
-soluble fiber
-plant stenols and sterols
-weight/exercise
-smoking cessation
omega-3
-reduce TG
-lovaza 2-4g qd or BID
-Vascepa 2g BID wf (IPE)
-caution AFIB
Statin high intensity
-atorvastatin 40-80mg
-rosuvastatin 20-40mg
Lipophillic statins
-fluva
-pitava
-lova
-simva
-atorva
-more likely for muscle pain
Hydrophillic
-pravastatin
-rosuvastatin
-inc liver toxicity
statins and muscle injury
-if CYP3A4 watch interactions, try CoQ10 before starting statin again
-switch hydrophillic
-consider alt dosing
simvastatin contraindications
-conazoles
-thromycins
-HIV protease inhibitors
-gemfibrozil
-cyclosporin
-danazol
-verapamil and siltiazem at 10mg
-amlodipine at 20mg
Bile Acid Resins
-cholestyramine (Questran)
-colestipol (colestid)
-colesevelam (welChol)
-space apart other meds
-may inc TG
-GI effects
-interfere w fat-soluble ADEK
-hypernatremia and CL
-gi obstruction
BAR contraindications
-bilary obstruction (cholestyramine)
-hx bowel obstruction
-TG>500
-pancreatitis
BAR interactions
-acetaminophen
-TZDs
-warfarin
-digozin
-contraceptives
-steroids
-ezetimibe
-fibrates
Niacin flushing tx
-take ASA 325mg 30 min before
-close to meal
-avoid alc and hot drinks
-titrate up
Niacin probs
-hyperuricemia
-hyperglycemia
-inc LFTs
-inc levels of statins
Niacin contraindications
-hepatic disease
-peptic ulcer
-arterial hemorrhage
Ezetimibe
-combo w statin
-inhibit intestinal absorption
-block NPC1L1
-fatigue and GI upset
Fibrate probs
-GI, rash, myalgia, dizziness
-gallbladder, ESRD, liver disease
-inc levels of statins, sulfonylureas, warfarin
PCSK9 for
-ASCVD on max statin
-high risk and statin intolerant
-LDL>190 on max statin
Inclisiran
-similar to PCSK9 but dosed 2x year
Bempedoic acid
-works upstream of statin
-may lead to GOUT
-prob not gonna use
-dont use w simva or prava
red yeast rice active ingredient
-lovastatin
high intensity statin
-when LDL >190
-risk assess in DM and over 75y/o
-secondary prevention
nonstatin tx guidelines
- ezetimibe
- PCSK9 inhibitors
other: BAS
LDL goals
<100 primary
<70 secondary